Goldman Sachs’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-582,424
| Closed | -$11.6M | – | 6275 |
|
|
2023
Q1 | $11.6M | Buy |
582,424
+363,648
| +166% | +$6.28M | ﹤0.01% | 2282 |
|
|
2022
Q4 | $2.98M | Sell |
218,776
-124,969
| -36% | -$1.74M | ﹤0.01% | 3621 |
|
|
2022
Q3 | $4.76M | Buy |
343,745
+198,718
| +137% | +$2.95M | ﹤0.01% | 3175 |
|
|
2022
Q2 | $2.08M | Sell |
145,027
-19,959
| -12% | -$346K | ﹤0.01% | 4009 |
|
|
2022
Q1 | $3.73M | Sell |
164,986
-35,250
| -18% | -$684K | ﹤0.01% | 3626 |
|
|
2021
Q4 | $3.76M | Buy |
200,236
+62,452
| +45% | +$1.67M | ﹤0.01% | 3698 |
|
|
2021
Q3 | $4.52M | Buy |
137,784
+88,023
| +177% | +$3.28M | ﹤0.01% | 3448 |
|
|
2021
Q2 | $2.12M | Sell |
49,761
-9,480
| -16% | -$371K | ﹤0.01% | 4152 |
|
|
2021
Q1 | $2.27M | Sell |
59,241
-4,685
| -7% | -$199K | ﹤0.01% | 3865 |
|
|
2020
Q4 | $2.8M | Sell |
63,926
-56,663
| -47% | -$2.13M | ﹤0.01% | 3477 |
|
|
2020
Q3 | $4.75M | Sell |
120,589
-108,415
| -47% | -$3.5M | ﹤0.01% | 2947 |
|
|
2020
Q2 | $7.23M | Sell |
229,004
-124,682
| -35% | -$4.66M | ﹤0.01% | 2508 |
|
|
2020
Q1 | $12.5M | Buy |
353,686
+167,616
| +90% | +$7.07M | ﹤0.01% | 1899 |
|
|
2019
Q4 | $9.04M | Buy |
186,070
+31,031
| +20% | +$1.41M | ﹤0.01% | 2504 |
|
|
2019
Q3 | $7.37M | Buy |
155,039
+41,742
| +37% | +$1.96M | ﹤0.01% | 2555 |
|
|
2019
Q2 | $4.86M | Sell |
113,297
-150,048
| -57% | -$5.82M | ﹤0.01% | 2867 |
|
|
2019
Q1 | $10.2M | Buy |
263,345
+184,691
| +235% | +$6.26M | ﹤0.01% | 2396 |
|
|
2018
Q4 | $2.24M | Buy |
78,654
+8,794
| +13% | +$279K | ﹤0.01% | 3459 |
|
|
2018
Q3 | $2.73M | Buy |
69,860
+40,989
| +142% | +$1.52M | ﹤0.01% | 3395 |
|
|
2018
Q2 | $934K | Buy |
28,871
+3,671
| +15% | +$101K | ﹤0.01% | 4123 |
|
|
2018
Q1 | $553K | Sell |
25,200
-23,473
| -48% | -$564K | ﹤0.01% | 4421 |
|
|
2017
Q4 | $1.15M | Sell |
48,673
-28,429
| -37% | -$717K | ﹤0.01% | 4220 |
|
|
2017
Q3 | $2.17M | Sell |
77,102
-53,195
| -41% | -$1.62M | ﹤0.01% | 3912 |
|
|
2017
Q2 | $4.2M | Sell |
130,297
-27,097
| -17% | -$826K | ﹤0.01% | 3209 |
|
|
2017
Q1 | $4.45M | Buy |
157,394
+13,654
| +9% | +$363K | ﹤0.01% | 3032 |
|
|
2016
Q4 | $3.48M | Sell |
143,740
-97,683
| -40% | -$2.4M | ﹤0.01% | 3376 |
|
|
2016
Q3 | $5.73M | Buy |
+241,423
| New | +$5.29M | ﹤0.01% | 2926 |
|
|
2015
Q4 | – | Sell |
-20,067
| Closed | -$318K | – | 7414 |
|
|
2015
Q3 | $318K | Buy |
+20,067
| New | +$506K | ﹤0.01% | 5561 |
|
|
2015
Q2 | – | Sell |
-7,655
| Closed | -$299K | – | 7494 |
|
|
2015
Q1 | $299K | Sell |
7,655
-289
| -4% | -$9.96K | ﹤0.01% | 5642 |
|
|
2014
Q4 | $239K | Buy |
+7,944
| New | +$227K | ﹤0.01% | 6009 |
|
|
2014
Q3 | – | Sell |
-33,986
| Closed | -$1.06M | – | 7312 |
|
|
2014
Q2 | $1.06M | Sell |
33,986
-10,535
| -24% | -$304K | ﹤0.01% | 4639 |
|
|
2014
Q1 | $1.42M | Buy |
44,521
+28,235
| +173% | +$933K | ﹤0.01% | 4328 |
|
|
2013
Q4 | $558K | Buy |
+16,286
| New | +$474K | ﹤0.01% | 5221 |
|
Other funds holding CSII
Goldman Sachs's CSII Position: Q2 2023 in Review
Goldman Sachs sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 582,424 shares — an estimated $11.6M sold.
Goldman Sachs first reported a position in CSII in Q4 2013 and held it in 33 quarters. The position peaked at $12.5M in Q1 2020. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- Goldman Sachs reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- Goldman Sachs sold 582,424 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $11.6M.
- Goldman Sachs first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and held it in 33 quarters.
- Goldman Sachs's Cardiovascular Systems, Inc. position peaked at $12.5M in Q1 2020.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.